NESTROFT—A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden

NESTROFT—A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden

Introduction β-Thalassemias are inherited hemoglobinopathies commonly encountered in practice. With chances of a promising cure being rare, the prevention of births with this disorder should assume priority, especially in low-resource countries. This can be achieved by the implementation of a mass s...

Full description

Bibliographic Details
Main Authors: Manasi Gosavi, Ramesh Chavan, M. B. Bellad
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-07-01
Series:Journal of Laboratory Physicians
Subjects:
nestroft
carrier screening
thalassemia trait
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1732493

Similar Items

Similar Items